Corporate Governance
Three long established core values guide Eli Lilly and Company in all that we do:
- Integrity - We conduct our business consistent with all applicable laws and are honest in our dealings with customers, employees, shareholders, partners, suppliers, competitors, and the community.
- Excellence - We pursue pharmaceutical innovation, provide high quality products, and strive to deliver superior business results. We continually search for new ways to improve everything we do.
- Respect for People - We maintain an environment built on mutual respect, openness, and individual integrity. Respect for people includes our concern for all people who touch or are touched by our company: customers, employees, shareholders, partners, suppliers and communities.
Building on these values, Lilly embraces the principle that we are at the forefront of good corporate governance and have strong, independent, and diverse membership on our board of directors.
Over the years, we have consistently sought to implement best governance practices. In today's climate of concern over corporate accountability, it is more important than ever that we continually earn investor confidence. We will do this by remaining a leader in good corporate governance and providing clear, consistent, and truthful communication about our performance.
By selecting the links below, you may access our corporate governance principles, other key corporate governance information, and our SEC filings. Visit the following links for information about our Comprehensive Compliance Program and the Declaration of Compliance. For copies of these documents, call The Lilly Answers Center at: 1-800-LillyRx (1-800-545-5979).
| Document | View | ||
|---|---|---|---|
| Corporate Governance Guidelines |
20.9 KB
|
||
| Code of Business Conduct |
7.1 KB
|
||
| Code of Ethical Conduct |
6.8 KB
|
||
| Articles of Incorporation |
29.4 KB
|
||
| By-Laws |
53.0 KB
|
||
| Committee Charters | View | ||
|---|---|---|---|
| Audit Committee Charter |
11.6 KB
|
||
| Compensation Committee Charter |
8.4 KB
|
||
| Directors and Corporate Governance Committee Charter |
7.6 KB
|
||
| Finance Committee Charter |
7.1 KB
|
||
| Public Policy and Compliance Committee Charter |
7.8 KB
|
||
| Science and Technology Committee Charter |
6.4 KB
|
||
| NYSE:LLY
$34.26 + 0.06 |
Sep 2, 2010
3:40 PM ET |




